Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading

By person

25 insiders · 464 transactions

0.3×

Julie Eastland holds only 0.3 times base salary in stock. $276.97K of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Julie Eastland last reported holding, valued at $3.50, the price Common Stock was last bought or sold at on the open market here, on 14 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Matrix Capital Management Company, LP entity

10% owner

$107.86M (1)

$9.98M (1)

+$97.89M

6,459,973

9.01%

$22.61M

−29.8%

Anthony Y Sun

President & CEO

$15.98K (1)

$32.77M (106)

−$32.75M

3,691,443

5.15%

$12.92M

−5.7%

Walters Group entity

10% owner

$22.92M (2)

—

+$22.92M

17,844,973

24.90%

$62.46M

+153.1%

Cam Gallagher

President, Interim CFO

—

$21.22M (131)

−$21.22M

633,680

0.8841%

$2.22M

+8.9%

Kevin D. Bunker

Chief Scientific Officer

$6.30K (1)

$20.77M (113)

−$20.76M

866,771

1.21%

$3.03M

−20.9%

Viking Global Investors LP entity

10% owner

$13.05M (1)

$25.25M (1)

−$12.20M

3,943,284

5.50%

$13.80M

+6.1%

Melissa B, Epperly

Chief Financial Officer

$859.75K (3)

$4.01M (46)

−$3.15M

451,449

0.6299%

$1.58M

+241.5%

Alexis Pinto

Chief Legal Officer

—

$2.37M (6) scheduled

−$2.37M

22,240

0.0310%

$77.84K

+7,958%

Dimitris Voliotis

SVP, Clinical Development

—

$1.87M (11) scheduled

−$1.87M

15,978

0.0223%

$55.92K

—

David Michael Johnson

Director

$239.94K (2)

$2.08M (8)

−$1.84M

307,521

0.4291%

$1.08M

+399.5%

Kimberly Blackwell

Chief Executive Officer

$51.45K (1)

$323.63K (4) scheduled

−$272.18K

484,145

0.6755%

$1.69M

—

Carrie Brownstein

Chief Medical Officer

—

$207.30K (2) scheduled

−$207.30K

105,685

0.1475%

$369.90K

—

Vincent Vultaggio

PAO and PFO

—

$115.01K (7) scheduled

−$115.01K

146,506

0.2044%

$512.77K

+313.2%

Andrea Paul

Chief Legal Officer

—

$60.84K (2)

−$60.84K

1,070,784

1.49%

$3.75M

—

Mark Lackner

Chief Scientific Officer

—

$56.64K (3)

−$56.64K

512,856

0.7156%

$1.79M

+3,044%

Diana Hausman

Chief Medical Officer

—

$42.35K (1)

−$42.35K

373,876

0.5216%

$1.31M

—

Ingmar Bruns

Chief Medical Officer

$45.66K (1)

$8.00K (2)

+$37.66K

43,059

0.0601%

$150.71K

—

Scott Dunseth Myers

Director

$29.37K (1)

—

+$29.37K

395,895

0.5524%

$1.39M

—

Julia Marie Eastland

CEO & President

$49.34K (1)

$21.24K (2)

+$28.11K

79,133

0.1104%

$276.97K

—

Luke Nathaniel Walker

Director

$24.97K (1)

—

+$24.97K

201,384

0.2810%

$704.84K

—

Jan Skvarka

Director

$103.45K (1)

$125.24K (1) scheduled

−$21.79K

264,254

0.3687%

$924.89K

—

Enoch Kariuki

Director

—

194,465

0.2713%

$680.63K

—

Shannon Campbell

Director

—

114,200

0.1593%

$399.70K

—

Iris Roth

Chief Operating Officer

—

52,500

0.0733%

$183.75K

—

Recurium Equity, LLC entity

10% owner

—

14,990

0.0209%

$52.47K

−99.6%

Zentalis Pharmaceuticals, Inc.

What the insiders did Net buying

By person